EC Number | Application | Comment | Organism |
---|---|---|---|
2.4.3.8 | diagnostics | enzyme expression predicts poor clinical outcome in breast cancer | Homo sapiens |
2.4.3.8 | drug development | the enzyme can serve as a potential druggable target for inhibiting tumor initiation and metastasis. GD3S expression correlates with activation of the c-Met signaling pathway leading to increased stem cell properties and metastatic competence, the GD3S-c-Met axis might serve as an effective target for the treatment of metastatic breast cancers | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.3.8 | gene ST8SIA1, quantitative reverse-transcription PCR enzyme expression analysis | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.4.3.8 | additional information | analysis of the role of enzyme GD3S in primary tumor formation and metastasis in syngeneic wild-type BALB/c mice, in which tumors are developed, and in 4T1 cells, inhibiting or supressing the enzyme by triptolide-treatment and expressing control shRNA or GD3S shRNA, respectively. FOXC2 is silenced in MDA-MB-231 and HMLE-Snail cells. Phenotypes, overview | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.3.8 | triptolide | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 | Homo sapiens | - |
CMP + ganglioside GD3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.3.8 | Homo sapiens | Q92185 | gene ST8SIA1 | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.3.8 | breast cancer cell | - |
Homo sapiens | - |
2.4.3.8 | MCF-10A cell | - |
Homo sapiens | - |
2.4.3.8 | MDA-MB-231 cell | - |
Homo sapiens | - |
2.4.3.8 | SUM-159PT cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 | - |
Homo sapiens | CMP + ganglioside GD3 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.3.8 | GD3 synthase | - |
Homo sapiens |
2.4.3.8 | GD3S | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.4.3.8 | Homo sapiens | transcription factor FOXC2, a central downstream effector of several epithelial-mesenchymal transition pathways, directly regulates GD3S expression by binding to its promoter | additional information |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.4.3.8 | malfunction | inhibition of the enzyme using small hairpin RNA or triptolide compromises the initiation and maintenance of epithelial-mesenchymal transition instigated by various signaling pathways, including Snail, Twist and transforming growth factor-beta1 as well as the mesenchymal characteristics of claudin-low breast cancer cell lines, SUM159 and MDA-MB-231. Inhibition of enzyme GD3S in vivo prevents metastasis, it inhibits invasion and motility of cancer cells | Homo sapiens |
2.4.3.8 | physiological function | GD3 synthase is a critical enzyme involved in GD2 biosynthesis. The enzyme is necessary for wound healing, migration, invasion and stem cell properties in vitro. The enzyme has an important role in the initiation and maintenance of epithelial-mesenchymal transition. Transcription factor FOXC2, a central downstream effector of several epithelial-mesenchymal transition pathways, directly regulates GD3S expression by binding to its promoter. Enzyme GD3S expression correlates with activation of the c-Met signaling pathway leading to increased stem cell properties and metastatic competence | Homo sapiens |